Yield10 Bioscience Inc (NASDAQ: YTEN): Moving Toward A Higher Share Price

Yield10 Bioscience Inc (NASDAQ:YTEN) shares, rose in value, with the stock price up by 41.41% to the previous day’s close as strong demand from buyers drove the stock to $0.31.

Actively observing the price movement in the last trading, the stock closed the session at $0.22. The value of beta (5-year monthly) was 1.52. Referring to stock’s 52-week performance, its high was $3.29, and the low was $0.18. On the whole, YTEN has fluctuated by 24.69% over the past month.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


With the market capitalization of Yield10 Bioscience Inc currently standing at about $3.73 million, investors are eagerly awaiting this quarter’s results, scheduled for Mar 12, 2024 – Mar 18, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.11, which is expected to increase to -$0.15 for fiscal year -$0.75 and then to about -$0.85 by fiscal year 2025. Data indicates that the EPS growth is expected to be 58.80% in 2025, while the next year’s EPS growth is forecast to be -13.30%.

Analysts have estimated the company’s revenue for the quarter at $1.87 million, with a low estimate of $1.5 million and a high estimate of $2.25 million. According to the average forecast, sales growth in current quarter could jump up 3,016.70%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $2.25 million, representing an increase of 3,650.00% from the revenues reported in the last year’s results.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were 2 upward and no downward review(s) in last seven days. We see that YTEN’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium term indicators have put the stock in the category of Hold while long term indicators on average have been pointing out that it is a Hold.

The stock’s technical analysis shows that the PEG ratio is about 0, with the price of YTEN currently trading nearly 4.99% and 14.58% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 51.30, while the 7-day volatility ratio is showing 41.14% which for the 30-day chart, stands at 22.98%. Furthermore, Yield10 Bioscience Inc (YTEN)’s beta value is 1.65, and its average true range (ATR) is 0.08.

A comparison of Yield10 Bioscience Inc (YTEN) with its peers suggests the former has fared considerably weaker in the market. YTEN showed an intraday change of 41.41% in last session, and over the past year, it shrunk by -88.73%%.

Data on historical trading for Yield10 Bioscience Inc (NASDAQ:YTEN) indicates that the trading volumes over the past 10 days have averaged 16.86 million and over the past 3 months, they’ve averaged 4.60 million. According to company’s latest data on outstanding shares, there are 12.03 million shares outstanding.

Nearly 18.81% of Yield10 Bioscience Inc’s shares belong to company insiders and institutional investors own 5.07% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.24 million shares as on Mar 15, 2024, resulting in a short ratio of 0.98. According to the data, the short interest in Yield10 Bioscience Inc (YTEN) stood at 2.00% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 0.35 million. The stock has risen by 30.00% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the YTEN stock heading into the next quarter.